Fabtech Technologies (BOM:544558) Research & Development: ₹0 Mil (TTM As of Mar. 2026)


BOM:544558 Fabtech Technologies Ltd BOM:544558
20 GF Score
Price ₹156.75
! 4 Warning Signs
View Full Analysis

What is Fabtech Technologies Research & Development?

Fabtech Technologies BOM:544558 -0.98% 20 Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:544558 with a GF Score™ of 20/100. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Fabtech Technologies's Research & Development for the three months ended in Mar. 2026 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Fabtech Technologies  (BOM:544558) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Fabtech Technologies Research & Development Related Terms

Fabtech Technologies Research & Development Historical Data

* Premium members only.

The historical data trend for Fabtech Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fabtech Technologies Research & Development Chart

Fabtech Technologies Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
0.00 0.00 0.00 0.00 0.00

Fabtech Technologies Quarterly Data
Mar22 Mar23 Mar24 Dec24 Mar25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
BOM:544558
20GF Score
Fabtech Technologies Ltd BOM:544558
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fabtech Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0 Mil mean?
Fabtech Technologies (BOM:544558) has a Research & Development of ₹0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Fabtech Technologies and its competitors.
Is Fabtech Technologies' Research & Development too high?
Fabtech Technologies' current Research & Development is ₹0 Mil. Overall, Fabtech Technologies has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Fabtech Technologies' Research & Development compare to VEEV and BTSG?
Fabtech Technologies' Research & Development of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Fabtech Technologies and its competitors. Fabtech Technologies's current Research & Development is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fabtech Technologies stock overvalued right now?
Fabtech Technologies (BOM:544558) has a current Research & Development of ₹0 Mil. The current Research & Development is ₹0 Mil. Fabtech Technologies' overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Fabtech Technologies (BOM:544558), the current Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Fabtech Technologies Business Description

Other Exchanges FABTECH:India
Address Street 16, MIDC Central Road, Plot No D8, 1st Floor, ABR Emerald, MIDC Andheri East, Chakala MIDC, Mumbai, MH, IND, 400093
Fabtech Technologies Ltd is engaged in building pharmaceutical, biotech, and healthcare capabilities for a wide range of customers by offering comprehensive start-to-finish turnkey solutions, which include supplying pharmaceutical machinery/equipment, in-house designing and engineering, procurement, installation, validation, and undertaking other activities required in various projects, including standalone equipment supply and installation. The company provides solutions for clean air, manufacturing processes, purified water and pure steam generation and distribution, etc. The majority of its revenue is generated from the trading of pharmaceutical and surgical products. Geographically, the company derives maximum revenue from international markets, and the rest from its business in India.
20GF Score

Get the complete analysis for BOM:544558

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹156.75
Price